Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sensitive competitive-binding ELISAs for quantifying free kappa and lambda light chains in cerebrospinal fluid.

G L Stanescu1, A R Swick, V K Tuohy

  • 1Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, Ohio 44195.

Journal of Clinical Laboratory Analysis
|January 1, 1991
PubMed
Summary

New enzyme-linked immunoassays accurately measure free immunoglobulin light chains in cerebrospinal fluid. These assays offer a sensitive diagnostic tool for conditions like multiple sclerosis (MS).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiple Sclerosis Performance Test: validation of self-administered neuroperformance modules.

European journal of neurology·2020
Same author

Effect of intramuscular interferon beta-1a on gray matter atrophy in relapsing-remitting multiple sclerosis: A retrospective analysis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2015
Same author

Simple MRI metrics contribute to optimal care of the patient with multiple sclerosis.

AJNR. American journal of neuroradiology·2014
Same author

Prescribing recommendations for interferon-Beta in multiple sclerosis.

CNS drugs·2013
Same author

Successful cutaneous delivery of the photosensitizer silicon phthalocyanine 4 for photodynamic therapy.

Clinical and experimental dermatology·2011
Same author

Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis.

Neurology·2011

Area of Science:

  • Biochemistry
  • Immunology
  • Clinical Diagnostics

Background:

  • Elevated free kappa immunoglobulin light chains in cerebrospinal fluid (CSF) are a potential diagnostic marker for multiple sclerosis (MS).
  • Accurate quantification of free light chains is crucial for understanding neurological diseases.

Purpose of the Study:

  • To develop simple, sensitive, and standardized solid-phase enzyme-linked competitive binding immunoassays.
  • To quantify free kappa and lambda immunoglobulin light chains in CSF.

Main Methods:

  • Utilized polyclonal rabbit antibodies against Bence Jones proteins immobilized on Staphylococcal protein A.
  • Employed biotin-labeled Bence Jones proteins for standard curve generation and competitive binding.

Main Results:

Related Experiment Videos

  • Developed assays sensitive to the low nanogram range for free kappa and lambda light chains.
  • Demonstrated high specificity and acceptable precision for the developed immunoassays.
  • Results showed high correlation with previously established competitive-binding radioimmunoassays.

Conclusions:

  • The described immunoassays provide a reliable method for quantifying free immunoglobulin light chains in CSF.
  • These assays have potential utility as diagnostic markers, particularly for multiple sclerosis.
  • The assays are sensitive, specific, and standardized for clinical and research applications.